RNAM insider buying & filings

RNAMAvidity Biosciences, Inc.

—

19 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Feb 27 · scanned 3m ago

No price data yet — the yfinance scanner hasn't produced bars for RNAM.

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Short % float

Pro

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Feb 27RETURNMcCarthy TeresaChief Human Resources Officerdirect165,296 sh—

Feb 27RETURNThompson TamarDirectordirect6,692 sh—

Feb 27RETURNMacLean Michael FChief Financial Officerdirect133,977 sh—

Feb 27RETURNSkerjanec SimonaDirectordirect6,692 sh—

Feb 27RETURNHughes Steven GeorgeChief Medical Officerdirect115,857 sh—

Context

Coverage

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice